UNTOLD Ovarian Cancer Unmet Needs Survey
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Study ID
- NCT07070726
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this study is to comprehensively measure ongoing concerns and unmet needs of individuals living with ovarian cancer. To accomplish this, the UNderstanding The experience of Ovarian cancer - Life after Diagnosis (UNTOLD) study will be conducted using a mixed-methods approach. Ovarian cancer survivors will be enrolled to participate in UNTOLD to complete a one-time survey regarding their experiences. Up to 40 survivors will be subsequently identified to complete a follow-up interview. To ensure these sample sizes, along with a representative sample, a combined recruitment strategy will be employed using the California Cancer Registry (population-based) and recruitment through ovarian cancer advocacy groups.
Key Dates
- Start date
- Jul 10, 2025
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jan 1, 2028
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: Ovarian Cancer SurvivorsOvarian cancer survivors participate in UNTOLD by completing a one-time survey regarding their experiences
Primary Outcome Measure
Supportive Care Needs [ Time Frame: Day 1 ]
Central Contacts
- Rachel Vogel, PhD612-624-6928
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Masonic Cancer Center | Minneapolis | Minnesota | 55455 |
Find similar trials in Minneapolis, MN
Related Studies
- Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk WomenRecruiting · M.D. Anderson Cancer Center · Miami, Florida
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of PreventionRecruiting · University Medical Center Nijmegen · Chicago, Illinois